{
  "schemaVersion": 2,
  "eyebrow": "Cardiology",
  "title": "Acute Myocarditis",
  "summary": "Acute myocarditis requires rapid separation of uncomplicated inflammatory myocardial injury from acute coronary syndromes, fulminant shock, malignant arrhythmia, and biopsy-defined inflammatory syndromes requiring cause-directed immunosuppression or mechanical circulatory support.",
  "seoDescription": "Physician guide to acute myocarditis diagnosis, cardiac MRI, biopsy selection, shock stabilization, arrhythmia management, and activity restriction.",
  "clinicalQuestion": "How should physicians diagnose, risk-stratify, and manage suspected acute myocarditis while identifying patients requiring biopsy or circulatory support?",
  "specialty": "Cardiology",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "acute myocarditis",
    "fulminant myocarditis",
    "cardiac MRI",
    "Lake Louise criteria",
    "endomyocardial biopsy",
    "cardiogenic shock",
    "immune checkpoint inhibitor myocarditis"
  ],
  "keyTakeaways": [
    "Treat cardiogenic shock, sustained ventricular arrhythmia, or high-grade atrioventricular block as complicated myocarditis and escalate immediately to an advanced heart failure or critical care setting capable of mechanical circulatory support and endomyocardial biopsy. [2][3][21]",
    "In suspected acute myocarditis, obtain high-sensitivity troponin and use cardiac MRI as the principal noninvasive test for myocardial inflammation; the 2018 Lake Louise criteria improve diagnostic accuracy. [6][8][24]",
    "Chest pain with elevated troponin requires exclusion of acute coronary syndromes and other myocardial-injury mimics before assigning myocarditis as the working diagnosis. [1][9][19]",
    "Use guideline-directed heart failure and arrhythmia treatment when ventricular dysfunction or clinical heart failure is present; avoid initiating beta-blockers in heart block. [4][12][23]",
    "Restrict intense exercise after acute myocarditis and consider return to sport only after 3 to 6 months when the patient is asymptomatic, ventricular function is normal, inflammation has resolved, and arrhythmias are absent. [18][22]"
  ],
  "sections": [
    {
      "id": "triage-and-stabilization",
      "eyebrow": "Immediate decisions",
      "heading": "Identify complicated or fulminant myocarditis before completing the etiologic workup",
      "intro": "Hemodynamics, rhythm, and conduction status determine disposition and urgency of invasive evaluation.",
      "paragraphs": [
        "Admit patients with suspected myocarditis who have acute heart failure, hemodynamic instability, syncope with suspected arrhythmia, sustained ventricular arrhythmia, high-grade atrioventricular block, or rising troponin with evolving ventricular dysfunction. Fulminant myocarditis presents with sudden severe diffuse myocardial inflammation and may progress to cardiogenic shock, often requiring intravenous inotropes or mechanical circulatory support (MCS). [2][3][21]",
        "For cardiogenic shock, manage in an intensive care environment and involve advanced heart failure, interventional cardiology, electrophysiology, and cardiac surgery early. MCS is a bridge to recovery, diagnosis, or transplantation in patients whose perfusion cannot be maintained with pharmacologic support; the need for MCS should also accelerate planning for endomyocardial biopsy (EMB). [2][11][13][21]",
        "Place patients with new atrioventricular block, ventricular tachycardia, or ventricular fibrillation on continuous telemetry. Avoid beta-blockers in clinically significant heart block; use antiarrhythmics cautiously when ventricular dysfunction is present because negative inotropy may worsen heart failure. Patients with heart block may require pacing. [3][23]"
      ],
      "bullets": [
        "Treat acute pulmonary congestion and ventricular dysfunction with heart-failure-directed therapy, including diuretics when volume overloaded; use inotropic support when low output or shock is present. [23]",
        "Avoid NSAIDs in suspected viral myocarditis because they may impair myocardial healing and worsen inflammation. [23]",
        "Do not delay circulatory-support evaluation while awaiting cardiac MRI in shock or rapidly progressive ventricular failure. [2][21]"
      ],
      "subsections": [],
      "table": {
        "caption": "Disposition by high-risk clinical presentation. [2][3][18][21]",
        "columns": [
          "Presentation",
          "Immediate action",
          "Diagnostic consequence"
        ],
        "rows": [
          [
            "Cardiogenic shock or rapidly progressive severe LV failure",
            "ICU care; inotropic support and early MCS-capable advanced heart failure consultation. [2][3][21]",
            "Urgently evaluate for EMB when results may identify a treatable inflammatory subtype. [11][21]"
          ],
          [
            "Sustained ventricular arrhythmia or resuscitated cardiac arrest",
            "Continuous monitoring and acute arrhythmia management in a monitored setting. [3][22]",
            "Treat as complicated myocarditis; evaluate structural disease and inflammatory substrate. [18][22]"
          ],
          [
            "New high-grade AV block",
            "Telemetry; assess need for temporary pacing; avoid beta-blocker initiation. [3][23]",
            "Escalate evaluation for an inflammatory myocarditis phenotype requiring targeted treatment. [22][23]"
          ],
          [
            "Stable chest pain or mild heart-failure presentation",
            "Obtain ECG, high-sensitivity troponin, echocardiography, and evaluate for coronary disease and other mimics. [6][9][19]",
            "Proceed to cardiac MRI when clinical suspicion remains. [6][8][24]"
          ]
        ]
      }
    },
    {
      "id": "diagnostic-workup",
      "eyebrow": "Initial workup",
      "heading": "Confirm myocardial inflammation while excluding acute coronary syndrome and other mimics",
      "intro": "No isolated clinical feature establishes myocarditis; combine presentation with objective noninvasive abnormalities.",
      "paragraphs": [
        "Use the presenting syndrome to frame testing: acute chest pain, acute heart failure, new or recurrent unexplained arrhythmia, and cardiogenic shock are compatible clinical presentations. A suspected diagnosis is supported by at least one compatible presentation plus a diagnostic abnormality on noninvasive testing; asymptomatic patients require at least two diagnostic criteria. [18][19]",
        "Obtain a 12-lead ECG, serial high-sensitivity troponin, and transthoracic echocardiography. Elevated troponin is a common trigger for suspicion, but chest pain with troponin elevation also requires evaluation for acute coronary syndrome before myocarditis is assigned as the explanation. Echocardiography defines ventricular function and detects clinically important heart-failure physiology, while strain imaging may add diagnostic information in selected suspected cases. [6][9][10][19]",
        "Cardiac MRI is the noninvasive test of choice for suspected myocarditis because it evaluates myocardial edema and injury. Apply the 2018 Lake Louise criteria, which have high diagnostic accuracy and improve diagnostic performance relative to original criteria. MRI should complement, not replace, urgent invasive evaluation in unstable patients. [7][8][24]"
      ],
      "bullets": [
        "Trend troponin rather than using a single value to determine whether myocardial injury is ongoing; interpret the result with symptoms, ECG, ventricular function, and coronary evaluation. [6][9][19]",
        "Use echocardiography early to identify LV dysfunction, pericardial involvement, or hemodynamic consequences that alter admission level and treatment. [10][19]",
        "Use cardiac CT or invasive coronary evaluation when coronary anatomy must be clarified in a patient with chest pain and elevated troponin. [6][9]"
      ],
      "subsections": [
        {
          "heading": "When to pursue endomyocardial biopsy",
          "paragraphs": [
            "Consider EMB when myocarditis is complicated by shock, severe acute heart failure, high-grade atrioventricular block, or ventricular arrhythmias, particularly when histology could identify an inflammatory subtype requiring disease-specific immunosuppression. EMB is selectively required in fulminant presentations and remains the classic confirmatory diagnostic method for myocarditis. [11][21][22][23]",
            "Use biopsy findings to distinguish lymphocytic inflammation from eosinophilic myocarditis, giant cell myocarditis, cardiac sarcoidosis, or other inflammatory myocardial diseases. This distinction matters because autoimmune, giant cell, eosinophilic, and sarcoid-associated myocarditis may require maintenance immunosuppressive therapy rather than heart-failure treatment alone. [20][21][22]"
          ],
          "bullets": [
            "Do not use a stable cardiac MRI result as a reason to defer EMB in a deteriorating patient when histology could alter urgent treatment. [2][11][21]",
            "Coordinate EMB with a center able to provide MCS or transplant-level support when fulminant physiology is present. [2][13][21]"
          ]
        }
      ],
      "table": {
        "caption": "Diagnostic branch points in suspected acute myocarditis. [6][8][9][19][22][24]",
        "columns": [
          "Finding",
          "Interpretation",
          "Next step"
        ],
        "rows": [
          [
            "Chest pain plus elevated high-sensitivity troponin",
            "Myocardial injury; acute coronary syndrome and myocarditis are both plausible. [6][9][19]",
            "Assess ECG and coronary disease; obtain echocardiography and cardiac MRI if suspicion for myocarditis persists. [6][8][9]"
          ],
          [
            "Compatible syndrome plus noninvasive diagnostic abnormality",
            "Supports clinically suspected myocarditis. [19]",
            "Risk-stratify by ventricular function, rhythm, and hemodynamics; use MRI for noninvasive tissue characterization. [8][18][19]"
          ],
          [
            "Cardiac MRI meeting 2018 Lake Louise criteria",
            "Supports acute myocardial inflammation with improved diagnostic accuracy over original criteria. [24]",
            "Manage phenotype and severity; consider EMB if unstable or if pathology would change treatment. [21][22]"
          ],
          [
            "Shock, malignant arrhythmia, or high-grade AV block",
            "Complicated myocarditis with potential biopsy-defined treatable disease. [2][3][22]",
            "ICU-level management, early MCS assessment, and EMB consideration. [2][11][21]"
          ]
        ]
      }
    },
    {
      "id": "etiologic-branches",
      "eyebrow": "Etiology",
      "heading": "Use exposure history and pathology to identify myocarditis requiring cause-directed treatment",
      "intro": "Most patients need phenotype-guided supportive care; selected etiologies change the urgency and type of immunosuppression.",
      "paragraphs": [
        "Ask specifically about recent viral illness, autoimmune disease, new cancer immunotherapy, vaccination, cardiotoxic medication exposure, travel or epidemiologic risk, and systemic allergic or eosinophilic features. Viral infection is the most frequent cause in the United States and other developed countries, but myocarditis also follows autoimmune disease, vaccination, and cancer therapy. [16][23]",
        "Immune checkpoint inhibitor (ICI)-associated myocarditis is rare but potentially fatal. In a patient receiving cancer immunotherapy who develops troponin elevation, conduction disease, ventricular arrhythmia, heart failure, or compatible cardiac MRI findings, treat ICI exposure as a high-priority etiologic clue and coordinate urgent cardio-oncology evaluation; Lake Louise criteria can support MRI diagnosis in this setting. [1][7]",
        "Biopsy-directed treatment is most consequential when EMB identifies eosinophilic myocarditis, giant cell myocarditis, cardiac sarcoidosis, or autoimmune myocarditis. Maintenance immunosuppression is often required for autoimmune disease-associated myocarditis and for sarcoid, giant cell, or eosinophilic myocarditis; empiric intravenous corticosteroids are described for fulminant myocarditis or myocarditis causing acute heart failure, high-grade AV block, or ventricular arrhythmias. [20][22]"
      ],
      "bullets": [
        "Do not assume a recent viral syndrome establishes viral myocarditis or excludes other causes; biopsy becomes more valuable when the course is fulminant or electrically unstable. [21][23]",
        "In ICI-exposed patients, lower the threshold for urgent monitoring and multidisciplinary evaluation because myocarditis may be rapidly fatal. [1]",
        "Reserve longer-term immunosuppressive strategies for a defined inflammatory phenotype or systemic autoimmune condition rather than uncomplicated presumed viral myocarditis. [20][22]"
      ],
      "subsections": [],
      "table": {
        "caption": "Etiologic patterns that alter the next action. [1][7][16][20][22][23]",
        "columns": [
          "Clinical clue",
          "Priority diagnosis",
          "Actionable next step"
        ],
        "rows": [
          [
            "Recent flu-like illness, often 7 to 14 days before presentation",
            "Viral myocarditis. [23]",
            "Provide phenotype-based heart failure and rhythm treatment; avoid NSAIDs. [23]"
          ],
          [
            "Active or recent immune checkpoint inhibitor therapy",
            "ICI-associated myocarditis. [1]",
            "Urgent cardio-oncology assessment; cardiac MRI may support diagnosis, and assess for complicated disease requiring biopsy-directed care. [1][7][22]"
          ],
          [
            "Autoimmune disease or biopsy evidence of eosinophilic, giant cell, or sarcoid myocarditis",
            "Immune-mediated inflammatory myocarditis. [20][22]",
            "Use pathology and systemic disease assessment to guide corticosteroid-based and, when needed, maintenance immunosuppression. [20][22]"
          ],
          [
            "Shock, ventricular arrhythmia, or high-grade AV block regardless of trigger",
            "Fulminant or complicated myocarditis. [2][3][22]",
            "Prioritize ICU stabilization, MCS assessment, and EMB consideration over outpatient etiologic testing. [2][11][21]"
          ]
        ]
      }
    },
    {
      "id": "treatment-and-monitoring",
      "eyebrow": "Management",
      "heading": "Treat ventricular dysfunction and arrhythmias now, then reassess recovery before return to exercise",
      "intro": "Therapy is determined by hemodynamic phenotype and biopsy-defined etiology rather than by inflammation alone.",
      "paragraphs": [
        "For myocarditis with heart failure or ventricular dysfunction, initiate and titrate guideline-directed medical therapy as tolerated, using diuretics for congestion and standard heart-failure therapy for persistent systolic dysfunction. Acute myocarditis presenting as dilated cardiomyopathy is managed primarily with an optimal heart-failure regimen. [4][12][23]",
        "Manage arrhythmias according to clinical stability and ventricular function, recognizing that antiarrhythmic drugs can worsen heart failure through negative inotropy. Maintain monitoring for ventricular arrhythmias and conduction deterioration during the acute phase; use pacing when clinically significant heart block requires it. [3][22][23]",
        "Restrict physical activity until symptoms resolve and inflammatory markers normalize. At least 1 month may be needed for clinical remission, but return to sports should generally wait 3 to 6 months and requires absence of symptoms and arrhythmias, no ongoing inflammation, and normal LV systolic function. [18][22]"
      ],
      "bullets": [
        "Reassess LV systolic function and arrhythmia status before clearing strenuous exercise or competitive sport. [18]",
        "Continue heart-failure therapy when ventricular dysfunction persists rather than stopping treatment solely because acute symptoms improve. [4][12]",
        "Escalate refractory heart failure despite standard therapy to an advanced heart failure team because MCS or transplantation may be required. [13][22]"
      ],
      "subsections": [
        {
          "heading": "Monitoring priorities after discharge",
          "paragraphs": [
            "Follow recovery using symptoms, ventricular systolic function, inflammatory activity, and rhythm assessment, because return-to-play decisions require normal LV function, absence of arrhythmias, and no evidence of ongoing inflammation. Persistent ventricular dysfunction should continue to be managed as myocarditis-related cardiomyopathy with guideline-directed heart-failure therapy. [4][18]"
          ],
          "bullets": [
            "Do not clear athletic activity on symptom resolution alone; document the required functional, inflammatory, and rhythm recovery criteria. [18]",
            "Reevaluate patients with recurrent chest pain, worsening heart failure, syncope, new conduction disease, or ventricular arrhythmia for recurrent or persistent inflammatory myocardial disease. [18][19][22]"
          ]
        }
      ],
      "table": {
        "caption": "Treatment and activity decisions by clinical phenotype. [4][12][18][22][23]",
        "columns": [
          "Phenotype",
          "Management priority",
          "Monitoring or restriction"
        ],
        "rows": [
          [
            "Congestive heart failure with ventricular dysfunction",
            "Diuretics for congestion and guideline-directed heart-failure therapy as tolerated. [4][12][23]",
            "Reassess LV function; continue therapy when dysfunction persists. [4][12]"
          ],
          [
            "Low-output state or cardiogenic shock",
            "Inotropic support and early MCS assessment in an advanced center. [2][13][21][23]",
            "Use intensive hemodynamic and rhythm monitoring; evaluate for EMB. [2][11][21]"
          ],
          [
            "High-grade AV block or ventricular arrhythmia",
            "Continuous monitoring; pacing when needed; use antiarrhythmics cautiously in ventricular dysfunction. [3][22][23]",
            "Document absence of arrhythmia before return to strenuous exercise. [18]"
          ],
          [
            "Clinical recovery after acute myocarditis",
            "Maintain activity restriction until remission criteria are met. [18]",
            "Consider sport resumption after 3 to 6 months only with normal LV function, no arrhythmias, no ongoing inflammation, and no symptoms. [18]"
          ]
        ]
      }
    }
  ],
  "faq": [],
  "references": [
    {
      "number": 1,
      "title": "Myocarditis and look-alikes: when the diagnosis matters",
      "detail": "heart.bmj.com",
      "url": "https://heart.bmj.com/content/early/2026/01/20/heartjnl-2025-326381.abstract",
      "authors": "heart.bmj.com",
      "host": "heart.bmj.com"
    },
    {
      "number": 2,
      "title": "Recognition and Initial Management of Fulminant Myocarditis",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000745",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org"
    },
    {
      "number": 3,
      "title": "Diagnosis and Management of Myocarditis in Children",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000001001",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org"
    },
    {
      "number": 4,
      "title": "Management of Myocarditis-Related Cardiomyopathy in ...",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313578",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org"
    },
    {
      "number": 5,
      "title": "Clinical Characteristics and Mechanisms of Acute Myocarditis",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.124.324674",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org"
    },
    {
      "number": 6,
      "title": "Multimodality imaging in acute myocarditis",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1002/jcu.23310",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 7,
      "title": "Immune checkpoint inhibitor-related myocarditis: an illustrative ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ehjcr/article/6/1/ytab478/6513876",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 8,
      "title": "Assessing the Accuracy of Cine Post‐Contrast Cardiac ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1002/ird3.70088",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 9,
      "title": "Advanced Computed Tomography and Magnetic ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1111/echo.70106",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 10,
      "title": "The Utility of Strain Echocardiography in the Diagnosis ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/echo.70443",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 11,
      "title": "a position statement of the European Society of Cardiology ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/eurheartj/article/34/33/2636/408735",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 12,
      "title": "The management of myocarditis - Oxford Academic",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/eurheartj/article/32/21/2616/439730",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 13,
      "title": "Update on myocarditis – what we know so far and where we may be ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ehjacc/article-pdf/10/4/455/39217565/zuaa065.pdf",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 14,
      "title": "Myocarditis associated with COVID-19 and its vaccines",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0033062022001049",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 15,
      "title": "Review Paradigm shift in myocarditis treatment",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0914508723002034",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 16,
      "title": "Modeling immune checkpoint inhibitor associated ...",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S277297612400062X",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 17,
      "title": "“Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era”",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S2772487526000061",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 18,
      "title": "Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12608363",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 19,
      "title": "Acute Myocarditis - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK441847",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 20,
      "title": "Advances in myocarditis management in the light of the latest research and recent guidelines of the European Society of Cardiology",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11076022",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 21,
      "title": "Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10316338",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 22,
      "title": "Myocarditis: Diagnostic Modalities and Treatment Options",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11873950",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 23,
      "title": "Viral Myocarditis - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK459259",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 24,
      "title": "Comparison of Original and 2018 Lake Louise Criteria for ...",
      "detail": "pubs.rsna.org",
      "url": "https://pubs.rsna.org/doi/abs/10.1148/ryct.2019190010",
      "authors": "pubs.rsna.org",
      "host": "pubs.rsna.org"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "Myocarditis and look-alikes: when the diagnosis matters",
      "detail": "heart.bmj.com",
      "url": "https://heart.bmj.com/content/early/2026/01/20/heartjnl-2025-326381.abstract",
      "authors": "heart.bmj.com",
      "host": "heart.bmj.com",
      "snippet": "by M Marchetta · 2026 · Cited by 3 — Myocarditis related to immune checkpoint inhibitors is a rare but potentially fatal adverse effect of the use of cancer immunotherapy with checkpoint",
      "score": 0.3656158
    },
    {
      "number": 2,
      "title": "Recognition and Initial Management of Fulminant Myocarditis",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000745",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org",
      "snippet": "Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe diffuse cardiac inflammation often leading to death",
      "score": 0.51822984
    },
    {
      "number": 3,
      "title": "Diagnosis and Management of Myocarditis in Children",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000001001",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org",
      "snippet": "Fulminant myocarditis presents as cardiogenic shock; tachyarrhythmias are common, and inotropic or mechanical circulatory support (MCS) may be",
      "score": 0.46497503
    },
    {
      "number": 4,
      "title": "Management of Myocarditis-Related Cardiomyopathy in ...",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313578",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org",
      "snippet": "by C Tschöpe · 2019 · Cited by 334 — All patients with acute myocarditis should receive guideline-directed medical treatment for heart failure and arrhythmias, if applicable.48–50",
      "score": 0.44724357
    },
    {
      "number": 5,
      "title": "Clinical Characteristics and Mechanisms of Acute Myocarditis",
      "detail": "www.ahajournals.org",
      "url": "https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.124.324674",
      "authors": "www.ahajournals.org",
      "host": "www.ahajournals.org",
      "snippet": "by S Heymans · 2024 · Cited by 50 — In this review, we discuss the clinical aspects, pathogenesis, genetic susceptibility, and management of uncomplicated, complicated, and",
      "score": 0.43510985
    },
    {
      "number": 6,
      "title": "Multimodality imaging in acute myocarditis",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1002/jcu.23310",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "the diagnosis of myocarditis is mainly performed evaluating high-sensitive troponin followed by cardiac magnetic resonance or cardiac computed",
      "score": 0.56489134
    },
    {
      "number": 7,
      "title": "Immune checkpoint inhibitor-related myocarditis: an illustrative ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ehjcr/article/6/1/ytab478/6513876",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "by BJ Wintersperger · 2022 · Cited by 21 — Lake Louise Criteria appears useful in the cardiovascular magnetic resonance diagnosis of immune checkpoint inhibitor (ICI) myocarditis across",
      "score": 0.4497074
    },
    {
      "number": 8,
      "title": "Assessing the Accuracy of Cine Post‐Contrast Cardiac ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1002/ird3.70088",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "Cardiac MRI is considered the noninvasive diagnostic test of choice for myocarditis assessment due to its ability to evaluate myocardial",
      "score": 0.39985907
    },
    {
      "number": 9,
      "title": "Advanced Computed Tomography and Magnetic ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1111/echo.70106",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "In clinical practice, myocarditis is often suspected when patients present with acute chest pain and elevated troponins. There may be",
      "score": 0.36602354
    },
    {
      "number": 10,
      "title": "The Utility of Strain Echocardiography in the Diagnosis ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/echo.70443",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "by K Macierzanka · 2026 — Strain echocardiography has been shown to aid in the diagnosis of suspected myocarditis. This report aimed to synthesize available literature",
      "score": 0.21980645
    },
    {
      "number": 11,
      "title": "a position statement of the European Society of Cardiology ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/eurheartj/article/34/33/2636/408735",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "by ALP Caforio · 2013 · Cited by 4067 — ESC guidelines for the diagnosis and treatment of acute and chronic heart failure ... myocarditis patients rescued by mechanical circulatory support. ,. Crit Care",
      "score": 0.5617203
    },
    {
      "number": 12,
      "title": "The management of myocarditis - Oxford Academic",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/eurheartj/article/32/21/2616/439730",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "by HP Schultheiss · 2011 · Cited by 472 — The mainstay of treatment for myocarditis presenting as dilated cardiomyopathy is an optimal heart failure medical regimen.",
      "score": 0.44333586
    },
    {
      "number": 13,
      "title": "Update on myocarditis – what we know so far and where we may be ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ehjacc/article-pdf/10/4/455/39217565/zuaa065.pdf",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "Even with standard heart failure therapy the disease is often refractory leading to the require- ment for mechanical circulatory support or heart",
      "score": 0.4272061
    },
    {
      "number": 14,
      "title": "Myocarditis associated with COVID-19 and its vaccines",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0033062022001049",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "by A Rout · 2022 · Cited by 39 — Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis.",
      "score": 0.64182705
    },
    {
      "number": 15,
      "title": "Review Paradigm shift in myocarditis treatment",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0914508723002034",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "by U Yakhshimurodov · 2024 · Cited by 8 — Salerno, et al. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revasc Med, 23 (2021), pp. 107-113. View PDF",
      "score": 0.60750073
    },
    {
      "number": 16,
      "title": "Modeling immune checkpoint inhibitor associated ...",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S277297612400062X",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "by G Jensen · 2024 · Cited by 4 — Myocarditis most frequently occurs after viral infections, though it also commonly follows autoimmune diseases, vaccines, and cancer therapies[1]. While",
      "score": 0.54564947
    },
    {
      "number": 17,
      "title": "“Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era”",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S2772487526000061",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "indicates that even mild myocarditis confers an elevated long-term risk of adverse cardiovascular outcomes. Beyond clinical and imaging-based observations, recent advances highlight a critical role for host genetic susceptibility in modulating immune responses, myocardial injury, and disease severit",
      "score": 0.5278769
    },
    {
      "number": 18,
      "title": "Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12608363",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "Despite advances in diagnostic and therapeutic strategies, substantial evidence gaps persist in the field of myocarditis. The majority of current recommendations outlined in recent European guidelines remain grounded in small-scale studies or expert consensus. There is a pressing need for high-quali",
      "score": 0.7173491
    },
    {
      "number": 19,
      "title": "Acute Myocarditis - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK441847",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "## Evaluation\n\nThe ACC recommends a structured 5-step approach for evaluating and diagnosing acute myocarditis. This framework integrates clinical judgment with targeted diagnostic tools to ensure a comprehensive and systematic assessment.\n\nAccording to the 2013 European Society of Cardiology (ESC) ",
      "score": 0.7152057
    },
    {
      "number": 20,
      "title": "Advances in myocarditis management in the light of the latest research and recent guidelines of the European Society of Cardiology",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11076022",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "42.McCarthy RE, Boehmer JP, Hruban RH, _et al_. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. _N Engl J Med_. 2000. 342(10):690-695. doi: 10.1056/NEJM200003093421003 [DOI] [PubMed] [Google Scholar]\n   43.Heidenreich PA, Bozkurt B, Aguilar D, _et al_. 2",
      "score": 0.7001783
    },
    {
      "number": 21,
      "title": "Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10316338",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "18.McDonagh TA, Metra M, Adamo M et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726. doi: 10.1093/eurheartj/ehab368. [DOI] [PubMed] [Google Scholar]\n 19.Ginsberg F, Parrillo JE. Fulminant myocarditis. Crit Care Clin. 2013;29:4",
      "score": 0.6690754
    },
    {
      "number": 22,
      "title": "Myocarditis: Diagnostic Modalities and Treatment Options",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11873950",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "36.Heidenreich PA, Bozkurt B, Aguilar D, _et al_. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. _Circulation_. 2022. 145:0. doi: 10.1016/j.jacc.2021.12.012 [D",
      "score": 0.5401241
    },
    {
      "number": 23,
      "title": "Viral Myocarditis - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK459259",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "Along with providing supportive care, patients who present with heart failure and ventricular dysfunction should be treated according to current heart failure guidelines. Patients with heart failure often require diuretics and inotropic support. Long-term treatment with ACE inhibitors is recommended",
      "score": 0.4189114
    },
    {
      "number": 24,
      "title": "Comparison of Original and 2018 Lake Louise Criteria for ...",
      "detail": "pubs.rsna.org",
      "url": "https://pubs.rsna.org/doi/abs/10.1148/ryct.2019190010",
      "authors": "pubs.rsna.org",
      "host": "pubs.rsna.org",
      "snippet": "by JA Luetkens · 2019 · Cited by 291 — The 2018 Lake Louise criteria provide a high diagnostic accuracy for the diagnosis of acute myocarditis and significantly increase the",
      "score": 0.60386235
    }
  ],
  "publishedAt": "2026-08-24T17:11:48.346330+00:00",
  "updatedAt": "2026-08-24T17:11:48.346330+00:00",
  "readingMinutes": 6,
  "slug": "acute-myocarditis"
}